{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:26:12Z","timestamp":1753921572659},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.jns.2007.04.009","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T07:58:01Z","timestamp":1180511881000},"page":"240-243","source":"Crossref","is-referenced-by-count":12,"title":["Case of mononeuritis multiplex onset with rituximab therapy for Waldenstr\u00f6m's macroglobulinemia"],"prefix":"10.1016","volume":"260","author":[{"given":"Michelle L.","family":"Mauermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Shik","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2007.04.009_bib1","series-title":"Neurologic disorders in benign and malignant plasma cell dyscrasias","author":"Kelly","year":"2004"},{"issue":"22","key":"10.1016\/j.jns.2007.04.009_bib2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199805283382207","article-title":"Neuropathies associated with paraproteinemia","volume":"338","author":"Ropper","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2007.04.009_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1749-6632.1971.tb13560.x","article-title":"Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases","volume":"190","author":"Isobe","year":"1971","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.jns.2007.04.009_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2141.1982.tb02816.x","article-title":"Benign monoclonal gammopathy and peripheral neuropathy","volume":"51","author":"Osby","year":"1982","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.jns.2007.04.009_bib5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2007.04.009_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/WNL.43.7.1304","article-title":"Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS","volume":"43","author":"Suarez","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2007.04.009_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.jns.2007.04.009_bib8","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1212\/01.WNL.0000098996.02934.86","article-title":"Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab","volume":"61","author":"Rojas-Garcia","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2007.04.009_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mus.10359","article-title":"Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies","volume":"27","author":"Renaud","year":"2003","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.jns.2007.04.009_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/mus.20386","article-title":"Worsening after rituximab treatment in anti-mag neuropathy","volume":"32","author":"Broglio","year":"2005","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.jns.2007.04.009_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.jns.2007.04.009_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp.2005.071175","article-title":"Peripheral neuropathies in Waldenstrom's macroglobulinaemia","volume":"77","author":"Levine","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2007.04.009_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp.39.7.711","article-title":"Mononeuritis multiplex in a patient with macroglobulinaemia","volume":"39","author":"Fraser","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2007.04.009_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-88-3-360","article-title":"Waldenstrom's macroglobulinemia and mononeuritis multiplex","volume":"88","author":"Massey","year":"1978","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jns.2007.04.009_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.410220213","article-title":"Mononeuritis multiplex in Waldenstrom's macroglobulinemia","volume":"22","author":"Lamarca","year":"1987","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.jns.2007.04.009_bib16","first-page":"287","article-title":"Mononeuritis multiplex in a case of primary macroglobulinemia (author's transl)","volume":"80","author":"Tassin","year":"1980","journal-title":"Acta Neurol Belg"},{"issue":"7","key":"10.1016\/j.jns.2007.04.009_bib17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2005.03.144","article-title":"Diagnosis and management of Waldenstrom's macroglobulinemia","volume":"23","author":"Dimopoulos","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl 3","key":"10.1016\/j.jns.2007.04.009_bib18","first-page":"A385","article-title":"The natural history of peripheral neuropathy associated with cryoglobulinemia","volume":"54","author":"Klein","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2007.04.009_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004836-200605000-00018","article-title":"Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab","volume":"40","author":"Pekow","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.jns.2007.04.009_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.20207","article-title":"Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstrom macroglobulinemia does not indicate failure of response","volume":"77","author":"Ghobrial","year":"2004","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.jns.2007.04.009_bib21","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.04.009_bib22","first-page":"292b","article-title":"Polyneuropathy and vasculitis associated with IgG type I cryoglobulinemia can be treated effectively with the anti-CD20 monoclonal antibody (rituximab)","volume":"98","author":"Rosenthal","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jns.2007.04.009_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/keh503","article-title":"Rituximab inefficiency during type I cryoglobulinaemia","volume":"44","author":"Nehme-Schuster","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jns.2007.04.009_bib24","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1200\/JCO.2005.04.6474","article-title":"Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia","volume":"24","author":"Noronha","year":"2006","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jns.2007.04.009_bib25","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","article-title":"Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia","volume":"15","author":"Treon","year":"2004","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.jns.2007.04.009_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00003495-199958010-00009","article-title":"Rituximab","volume":"58","author":"Onrust","year":"1999","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jns.2007.04.009_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mus.880150805","article-title":"Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy","volume":"15","author":"Thomas","year":"1992","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.jns.2007.04.009_bib28","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/cncr.20658","article-title":"Initial immunoglobulin M \u2018flare\u2019 after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study","volume":"101","author":"Ghobrial","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jns.2007.04.009_bib29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","article-title":"Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy","volume":"48","author":"Silverman","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jns.2007.04.009_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0952-7915(99)80029-6","article-title":"B cell memory and the long-lived plasma cell","volume":"11","author":"McHeyzer-Williams","year":"1999","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.jns.2007.04.009_bib31","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2005-02-0833","article-title":"Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia","volume":"107","author":"Treon","year":"2006","journal-title":"Blood"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X0700264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X0700264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T20:58:25Z","timestamp":1546808305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X0700264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0022510X0700264X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2007.04.009","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}